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Abstract
Inflammation can be defined as the host response when confronted with an
aggression. The purpose of the inflammatory reaction is the defense of the
host for re-establishing the baseline homeostasis of the organism. Compared
to the neuroendocrine changes associated to the stress response to injury,
the inflammatory reaction is the major determinant of patient's recovery in the
perioperative period. Perioperative inflammation is involved in the occurrence
of various postoperative adverse outcomes other than only acute pain. By
consequence, perioperative strategies which limit or control the inflammatory
response might have beneficial effects on patient's recovery. The present
review summarizes the current knowledges on the interactions between some
of these strategies, specifically regional anesthesia (RA) techniques, and
inflammation in the context of perioperative medicine. Regional anesthesia
through its components i.e. local anesthetics and analgesic adjuvants like alpha-2
adrenerg...
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Perioperative inflammation: physiology 
and clinical consequences
Inflammation can be defined as the host re-
sponse when confronted with an aggression. The 
purpose of the inflammatory reaction is the de-
fense of the host for re-establishing the baseline 
homeostasis of the organism. Deficiencies or ex-
cesses of the inflammatory response cause mor-
bidity and shorten lifespan.1, 2
Inflammation is a complex phenomenon 
which involves many cells and mediators, both 
locally and systemically. Local mediators like 
cytokines synthetized at the site of tissue injury 
help to destroy infective agents, to prevent fur-
ther tissue damage and to activate wound heal-
ing. Inflammation and pain are interrelated as 
the local release of proinflammatory mediators 
also leads to peripheral sensitization, hence, pain 
augmentation (i.e. hyperalgesia). Some media-
tors are released into the circulation where they 
will induce a systemic inflammatory response 
(SIR) and act on distant organs e.g. interleukin 
(IL)-6 which will induce the synthesis of acute-
phase response proteins in the liver. Some oth-
ers like interleukin (IL)-1β crosses the blood 
brain barrier and will induce a state of inflam-
mation, “neuroinflammation”, into the central 
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A B S T R A C T
Inflammation can be defined as the host response when confronted with an aggression. The purpose of the inflam-
matory reaction is the defense of the host for re-establishing the baseline homeostasis of the organism. Compared 
to the neuroendocrine changes associated to the stress response to injury, the inflammatory reaction is the major 
determinant of patient’s recovery in the perioperative period. Perioperative inflammation is involved in the occur-
rence of various postoperative adverse outcomes other than only acute pain. By consequence, perioperative strategies 
which limit or control the inflammatory response might have beneficial effects on patient’s recovery. The present 
review summarizes the current knowledges on the interactions between some of these strategies, specifically regional 
anesthesia (RA) techniques, and inflammation in the context of perioperative medicine. Regional anesthesia through 
its components i.e. local anesthetics and analgesic adjuvants like alpha-2 adrenergic agonists (clonidine, dexmedeto-
midine) modulates the inflammatory response consecutive to tissue injury by various mechanisms, at different levels. 
While experimental studies have shown that RA techniques modulate both local and systemic inflammatory reac-
tions, in contrast, clinical findings are inconsistent as actual RA techniques fail to impact major patients’ outcomes 
beyond immediate postoperative analgesia. The discrepancy between experimental findings and clinical observations 
asks questions and argues for a different view of perioperative inflammatory processes, in other words for an indi-
vidualized management of the patients. Future developments of tools to quantify inflammatory and immune profile 
of patients might certainly lead to exciting findings and to major improvements in perioperative medicine.
(Minerva Anestesiol 2015;81:1001-9)
Key words: Inflammation - Perioperative care - Anesthesia.
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nervous system (CNS). Microglia (the immune 
cells of CNS) is first activated then astrocytes 
(the support cells of neurons), those later show-
ing a durable activation.3 Neuroinflammation 
is one of the mechanisms underlying central 
sensitization process.3 Whether acute inflamma-
tion is essential for recovery from tissue injury, 
when it persists, inflammatory processes underly 
both the development and the maintenance of 
chronic diseases like atherosclerosis, cancer, de-
mentia, obesity, asthma, chronic pain.2 Because 
of the deleterious consequences of uncontrolled 
inflammation, the inflammatory response is a 
highly regulated process. Termination of the in-
flammatory reaction is no more seen as a passive 
process by elimination of local pro-inflammato-
ry mediators but is considered as an active pro-
cess which involves the synthesis of specific pro-
resolving mediators (e.g. resolvins, protectins, 
maresins…) stimulating the resolution without 
immune suppression.2
Tissue lesions combined to anesthesia drugs 
and techniques are responsible for the impor-
tant inflammatory reaction and the suppres-
sion of cell-mediated immunity observed dur-
ing the perioperative period.1 Compared to the 
neuroendocrine changes associated to the stress 
response to injury, the inflammatory reaction is 
the major determinant of patient’s recovery in 
the perioperative period. Perioperative inflam-
mation is involved in the occurrence of various 
postoperative adverse outcomes other than acute 
pain:4 persistent pain, fatigue and delirium, car-
diovascular events, cancer recurrence. By conse-
quence, perioperative strategies which limit or 
control the inflammatory response might have 
beneficial effects on patient’s recovery. The pur-
pose of the present review is to summarize the 
current knowledges on the interactions between 
some of these strategies, specifically regional an-
esthesia (RA) techniques, and inflammation in 
the context of perioperative medicine (Figure 1).
Figure 1.—Consequences of perioperative inflammation.
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rogenic inflammation participates to the general 
inflammatory response.6
Besides, LAs also possess intrinsic anti-inflam-
matory properties of which all the mechanisms 
are not completely elucidated yet but differ from 
that of sodium channels blockade.7 LAs modu-
late various steps of the inflammatory cascade 
as summarized in Table I. In the context of RA 
techniques, LAs may act on regular immune 
cells e.g. macrophages recruited on injury site as 
well as they may interact with resident cells like 
keratinocytes and fibroblasts which are critically 
involved in local inflammatory and healing proc-
esses.8, 9 Furthermore, when used for RA, LAs 
may also be absorbed into the systemic circula-
tion. LAs attenuate the excessive inflammatory 
response without impairing the physiological 
host defense in contrast with other immunosup-
pressant drugs.10 Leucocytes have no sodium 
voltage-dependent channels yet their immune 
function is influenced by LAs at more than one 
level. Priming of leucocytes is currently consid-
ered as playing a major role in the “overstimula-
tion” of inflammatory pathways. The majority of 
inflammatory mediators (tumor necrosis factor 
–TNF-α, lipopolysaccharide [LPS], platelet ac-
tivating factor [PAF], interleukin [IL-8]) signal 
through G-protein coupled receptors to enhance 
the response of leukocytes. LAs significantly at-
tenuate G-protein mediated human neutrophil 
priming,11 the most potent inhibition being 
achieved by ester compounds and being inverse-
ly correlated with the octanol-buffer coefficient 
of the LA. Among other mechanisms involved in 
the anti-inflammatory effect of LAs, protection 
of the endothelial barrier reduces neutrophils ad-
hesion and endothelial hyperpermeability caus-
ing major organ dysfunction. Both ropivacaine 
and lidocaine effectively block pro-inflammato-
ry TNF-α signalling in endothelial cells.12 This 
Mechanisms by which RA modulates the 
perioperative inflammatory response
RA is a very popular technique, used alone or 
more frequently, in combination with general 
anesthesia to provide satisfactory postoperative 
analgesia in major thoracoabdominal and ortho-
pedic procedures. To date, however, the benefits 
of RA with regards to perioperative morbidity 
and mortality reduction continue to be debated.5 
Further, the benefits on later outcomes which are 
far different than postoperative pain control and 
which will condition patient’s rehabilitation and 
return to preoperative situation are not clear.5 As 
previously mentioned, individual’s inflamma-
tory response plays a major role in most if not all 
of these outcomes. Whether the impact of RA 
on the inflammatory response has been studied 
in various experimental models, well-designed 
clinical studies are scarce bringing unconclusive 
results. Nevertheless, without doubt, RA can 
modulate the inflammatory response consecu-
tive to tissue injury by various mechanisms, at 
different levels.
Local anesthetics (LAs) are the major com-
ponent of RA techniques. The most cited anti-
inflammatory mechanism of LAs is the interrup-
tion of nociceptive transmission at the injury site 
and the reduction of “neurogenic inflammation”. 
LAs block transmembrane proteins voltage-gated 
sodium channels on nociceptors sensitized by lo-
cally released pro-inflammatory mediators (pros-
taglandins E2, interleukins, etc.). Small-diame-
ter primary afferent fibers when sensitized also 
release pronociceptive neuropeptides (substance 
P, CGRP, neurokinin) within their immediate 
vicinity through an axon reflex mechanism. By 
consequence, reduction of neurogenic inflam-
mation by LAs will modulate both peripheral 
and central sensitizations processes as local neu-
Table I.— Mechanisms involved in modulation of inflammation by local anesthetics and analgesic adjuvants.
Effects on PMN Effects on the production of proinflammatory cytokines
↓ leukocyte adherence ↓ NF-kB signaling
↓ migration through the endothelium ↓ the axonal transport of TNF α
↓ phagocytosis ↓ the TNF α receptor expression in DRG
↓ ICAM-1expression ↓ PG biosynthesis and the release of TX B2 and LT B4
↓ the release of chemo-attracting agents ↓ synthesis of IL1 α, IL 1 β, IL 2, IL 8
↓ superoxide anion production of PAF-primed PMN ↓ synthesis of TNF α, IFN ϒ
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using opioid sparing regimens). So more studies 
should be performed, comparing RA with either 
opioid-sparing or opioid-free general anesthesia 
in order to state a clear anti-inflammatory effect 
of RA techniques. A recent review on preven-
tive analgesia by local anesthetics administered 
by either peripheral nerve blocks or intravenous 
route suggests that the significant analgesic and 
antihyperalgesic effect occurs for their use dur-
ing the postoperative period.17 It is worth noting 
that other outcomes different from only acute 
pain control have not be considered here and 
that, the intraoperative use of RA is mandatory 
to maximize the opioids sparing effect, hence the 
anti-inflammatory effect, of the technique.18
With RA, LAs are partly absorbed in the sys-
temic circulation. For anti-inflammatory effects 
of systemic LAs, special attention has been at-
tributed to intravenous lidocaine administra-
tion, particularly in major abdominal surgery. 
Postoperative ileus and systemic inflammation 
caused by surgery increase intestinal epithelial 
permeability which are associated with bacterial 
translocation and contribute to multiple organ 
failure. Meta-analysis have confirmed the early 
benefits of intravenous lidocaine in patients un-
dergoing abdominal procedures but surprisingly 
not in those undergoing other types of surger-
ies like cardiac or orthopaedic procedures (Table 
II).19
As intravenous lidocaine is also called “the 
poor man’s epidural”, it is interesting to deter-
mine the benefit related to the use of neuraxial 
blocks. In experimental conditions, epidural 
bupivacaine attenuates mesenteric ischemia-
reperfusion related inflammatory response and 
intestinal damage.20 Epidural lidocaine anesthe-
sia also reduces endotoxin-induced gut epithelial 
injury by decreasing monocytic extravasation 
and intestinal nitrosative stress.21 In patients un-
dergoing colonic surgery, thoracic epidural anal-
gesia with lidocaine provides better postopera-
tive pain relief and opioid sparing effect, earlier 
return of bowel function and lesser production 
of inflammatory cytokines than intravenous li-
docaine during 72 hours.22 The greater benefit 
of epidural lidocaine over systemic lidocaine cer-
tainly questions the role of the central sympa-
thetic nervous system in controlling the systemic 
mechanism may provide therapeutic benefit in 
acute inflammatory conditions including in the 
context of carcinologic surgery.10 It is also worth 
noting that LAs, specifically lidocaine, modu-
lates central neuroinflammation by decreasing 
the production of proinflammatory cytokines by 
microglial cells.13
Analgesic adjuvants used in RA techniques 
may also interfere with the inflammatory reac-
tion at different levels. Among these adjuvants, 
α2-adrenergic agonists clonidine and more re-
cently dexmedetomidine have been the most 
studied. Their capacity to modulate the inflam-
matory response caused by tissue injury mainly 
relies on α2-adrenergic receptors binding on 
stimulated proinflammatory cells like macro-
phages and leucocytes,14 yielding to reduction 
of the expression of Toll-like receptors (TLR) 4, 
hence to reduced activation and translocation of 
nuclear transcription factor NF-κB and subse-
quent decrease of pro-inflammatory cytokines 
production (Table I).15, 16
How different RA techniques affect the 
perioperative inflammatory response in 
animal models and clinical conditions
Two important concerns need to be raised 
preliminary. First, the relevance of the animal 
models used to the mimic clinical conditions. 
Carrageenan injection, i.e. a chemical irritant, is 
a pure inflammatory model not really represent-
ative of incisional pain. More, it is mandatory 
to take into account major immune differences 
between rodents and humans, yielding to con-
sider with caution extrapolation of animal data 
to patients. Second, inflammatory parameters 
in the majority of clinical studies are biased by 
the concommittant use of drugs which interfere 
with the immune and inflammatory responses. 
The most examplative is the administration of 
high doses of opioids in control groups without 
RA. Opioids display imuno-supressive effects 
and proinflammatory responses in the central 
nervous system likely via activation of micro-
glia.3 By consequence, better outcomes for the 
patients who benefit of RA could actually be 
translated as better outcomes for patients with 
no or less opioid intake (i.e. balanced anesthesia 
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that the modulation of the sympathetic nervous 
system effectively plays a role in controlling the 
SIR as aforementioned.26, 27 More, the reduc-
tion of the sympathetic outflow may increase the 
role of the parasympathetic system. The cholin-
ergic anti-inflammatory pathway through the 
stimulation of the vagus nerve is a well-known 
mechanism of neural inhibition of inflamma-
tory response. Acetylcholine, the principal neu-
rotransmitter of the vagus, dose-dependently in-
hibits the release of pro-inflammatory cytokines 
by macrophages.28
A series of experimental studies using the 
carrageenan model of peripheral inflammation 
in rats have questioned the anti-inflammatory 
properties of peripheral nerve blocks.29 The 
authors have demonstrated that LAs act at dif-
ferent levels when administered systemically or 
via a nerve block. To summarize, LAs peripheral 
nerve blocks decrease both paw edema and hy-
peralgesia caused by local tissue inflammation, 
even when the nerve block is performed on the 
contralateral limb. Systemic absorption of LAs 
partly may explain the anti-inflammatory effect 
of a contralateral nerve block. Both systemic ad-
ministration of LAs and perineural one reduce 
the systemic inflammatory response (SIR) while 
systemic LAs have no effect on paw edema and 
local hyperalgesia.30 Spinal increase of prosta-
glandin (PG) E2 correlates with pain and hyper-
algesia after tissue injury in animal models and 
inflammatory response.23 Regional sympathetic 
block increases intestinal perfusion. Further, the 
sympathetic nervous system shows overactivity 
under stress conditions i.e. surgical trauma and 
RA may help to modulate this overeactivity and 
to re-establish the immune balance in the perio-
perative period. Most of the studies assessing the 
anti-inflammatory effect of neuraxial anesthesia 
and analgesia have compared the combination of 
epidural with general anesthesia to general anes-
thesia alone. The results have been disappointing, 
showing only partial and temporary effect on the 
acute inflammatory stress response in term of cy-
tokines expression.24 Spinal anesthesia exhibits 
perioperative anti-inflammatory properties that 
seem to be moderate and transient when com-
pared with epidural anesthesia. Spinal anesthesia 
is often used for relatively short lasting proce-
dures. By example, in patients undergoing knee 
arthroplasty, no difference was found regarding 
systemic modulation of the inflammatory re-
sponse between spinal anesthesia followed by 
systemic morphine analgesia and epidural anes-
thesia followed by postoperative epidural analge-
sia.25 Regarding the analgesic adjuvants, it is well 
known that α2-adrenergic agonists blunt central 
sympathetic outflow. Compared with epidural 
bupivacaine, epidural clonidine demonstrates 
greater anti-inflammatory effects (reduction of 
systemic proinflammatory cytokines expres-
sion) after colorectal surgery, what lets suppose 
Table II.— Modulation of perioperative inflammatory reaction by local anesthetics in experimental and clinical conditions: 
comparison of RA and systemic administration.
Clinical parameters Biological parameters
Edema, 
redness
Pain, 
hyperalgesia
Local 
cytokines
Systemic 
cytokines Spinal PGE2
Abdominal visceral surgery
Laparotomy model – rat 34 CWI ropivacaine
Systemic
ropivacaine
NA
NA
+
+
0
+
0
++
NA
NA
Laparotomy – human 22 Epidural lidocaine
Intravenous lidocaine
NA
NA
++
+
NA
NA
++
+
NA
NA
Orthopedic limb surgery
Carrageenan model – rat 29, 30 PNB bupivacaine
Systemic bupivacaine
+
0
++
0
+
0
++
++
+
0
Knee arthroplasty – human 31, 32 PNB bupivacaine / 
ropivacaine
+ ++ 0 0 NA
RA: regional anesthesia; CWI: continuous wound infusion; PNB: peripheral nerve block.
(+) positive modulatory effect of inflammatory parameters i.e. reduction of inflammation; (0) no modulatory effect of inflammatory parameters.
NA: data not available.
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TNF-α and IL-1β in whole blood and perito-
neal macrophages cultures). In humans, there 
is a lack of correlation between systemic i.e. se-
rum levels and local expression of intra wound 
cytokines and PGs after caesarean section.8 In 
the same clinical model, continuous intrawound 
infusion of bupivacaine seemed to enhance the 
local proinflammatory response while showing 
clinical analgesic effects 9. Recent experimental 
data have highlighted the proinflammatory ef-
fect of bupivacaine on peripheral nerve and the 
protective effect of the α2-adrenergic agonist 
dexmedetomidine in that setting.35 Moreover, 
local injection of dexmedetomidine counter-
acts the inflammatory reaction caused by in-
traplantar carrageenan in rats as it reduces paw 
edema, leucocytes activation and decreases the 
local production of TNF-α and the local expres-
sion of COX-2.36
RA, inflammatory response and patient’s 
outcomes in clinical practice
While it is clear from experimental data that 
RA display anti-inflammatory and immunologic 
modulatory properties, in clinical practice the 
impact on perioperative inflammation is not so 
evident. First, there is clearly a dissociation be-
tween the clinical effects reported (i.e. reduction 
of local edema and acute pain) and the modu-
lation of the biologic markers of inflammation 
(i.e. local cytokines expression), particularly in 
orthopaedic setting. Second, RA benefits in term 
of patients’ major outcomes, other than acute 
pain control (e.g. persistent pain and cancer re-
currence) are unconclusive. Epidural anesthesia 
and paravertebral block, respectively, may pre-
vent persistent postsurgical pain after thoracot-
omy and breast surgery in about one out every 
four to five patients.37 In orthopedic procedures, 
where long-lasting preoperative pain and inflam-
mation are very common, the benefits are even 
less evident as 4-days continuous peripheral 
nerve blocks only improve rehabilitation at 6 
weeks after hip or knee arthroplasty but not later 
and do not prevent the development of persist-
ent pain.38 Inflammation not only plays a central 
role at different stages of tumor development but 
also contributes to the initiation of antitumoral 
clinical situations.4 After hindpaw carrageenan 
injection, bupivacaine sciatic block inhibits 
COX-2 expression in both dorsal root ganglion 
and spinal cord, leading to a reduction of spinal 
PGE2, while systemic bupivacaine administra-
tion does not modify COX-2 expression.30 In 
humans, the anti-inflammatory effects of pe-
ripheral nerve blocks have been explored after 
major orthopaedic procedures like knee arthro-
plasty.31, 32 Despite the use of continuous nerve 
blocks with bupivacaine or ropivacaine, the 
inflammatory parameters i.e. systemic and lo-
cal cytokines expression were not really affected 
while knee edema, early postoperative pain and 
mobilization were improved in the block groups. 
Peri-neural administration of clonidine in the 
context of nerve injury reduces the development 
of hypersensitivity by altering the balance of pro- 
and anti-inflammatory cytokines locally released 
during the process of Wallerian degeneration.14 
Drug effect is mediated through binding to α2-
adrenergic receptors expressed on local mac-
rophages. Similar findings have been recently 
reported for dexmedetomidine, which is more 
selective for α2-adrenergic receptors than clo-
nidine.15 Here, it is interesting to mention that 
systemic administration of clonidine improves 
posthypoxic endothelial function and modulates 
inflammation during limb reperfusion in both 
animal models and healthy volunteers.33
Wound infiltration is a non-invasive, easy 
technique often considered as useful adjunct 
to multimodal analgesia for postoperative pain 
management as it reduces pain and shows an 
opioid sparing effect. The catheter location is 
important because of the role played by deep 
structures into postoperative pain e.g. deep mus-
cular layers, peritoneum. Today, pre-peritoneal 
infusion of LAs is considered as an alternative 
to epidural analgesia for abdominal procedures. 
Using an animal model of laparotomy, Kfoury et 
al.34 have tried to explain the mechanisms of ac-
tion involved in intrawound LAs analgesic effect. 
They have demonstrated that both high doses of 
preperitoneal infusion of ropivacaine and sys-
temic ropivacaine similarly reduced mechanical 
and visceral sensitivity while systemic adminis-
tration alone was associated with an anti-inflam-
matory effect (reduced stimulated production of 
              COPYRIGHT© 2015 EDIZIONI MINERVA MEDICA 
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ancies between local and systemic expression of 
common cytokines are usually noted, and clini-
cal reduction of pain and inflammation does 
not really correlates with decrease in biological 
makers.31, 32 Such inflammation-based scores 
are already used to assess the prognostic of can-
cer patients 43 but prospective studies aimed to 
validate them in perioperative situations are cur-
rently missing. It is also interesting to note that 
RA impact on the mediators involved in the ac-
tive resolution of inflammation has not yet been 
assessed.2
Conclusions
Compared to the neuroendocrine changes 
associated to the stress response to injury, the 
inflammatory reaction is the major determi-
nant of patient’s recovery in the perioperative 
period. Uncontrolled inflammation is involved 
in the majority of adverse outcomes after sur-
gery. Experimental studies have shown that RA 
techniques using LAs and analgesic adjuvants 
modulate both local and systemic inflamma-
tory reaction caused by surgical injury. In con-
trast, clinical findings are inconsistent as actual 
RA techniques fail to impact major patients’ 
outcomes beyond immediate postoperative an-
algesia. The discrepancy between experimental 
findings and clinical observations ask questions 
and argues for a different view of perioperative 
inflammatory processes, in other words for indi-
vidualized management of the patients. Future 
developments of tools to quantify inflammatory 
and immune profile of patients might certainly 
lead to exciting findings and to major improve-
ments in perioperative medicine.
immune response.39 In regard to that complex 
situation, it is not surprising that systematic re-
views based on retrospective studies have found 
little evidence to support major benefit of RA on 
survival after oncologic surgery.40, 41
Unsolved issues and questions deserving 
future research in the field
The poor clinical results certainly incite us to 
question the reasons for RA failure to influence 
longterm outcomes. First, the severity and the 
duration of ongoing perioperative inflammatory 
processes may differ from one individual to the 
other. Experimental data have clearly shown that 
a prolonged nerve block is necessary to decrease 
the systemic consequences of the local inflam-
matory reaction 6 as well as only repeated peri-
neural injections of clonidine modulate local 
cytokines expression yielding to longlasting de-
crease of hypersentisivity 14. Under clinical con-
ditions, prolonged peripheral nerve blocks i.e. 
lasting longer than the usual postoperative dura-
tion (2 to 4 days) might be necessary to control 
perioperative inflammation and to demonstrate 
beneficial effect on patient’s outome as demon-
strated in the context of limb amputation (medi-
an duration of sciatic block of 30 days; extreme 
values 3 to 80 days).42 Second, studies have not 
taken into account the preoperative basal status 
of the patients while several preoperative condi-
tions are “inflammatory prone” like asthma, ob-
sesity, rheumatoid arthritis, inflammatory bowel 
diseases, what could have blunted the impact of 
some RA techniques. The widespread use of ul-
trasounds has contributed to RA success in both 
acute and chronic pain settings. In the periop-
erative period, the anti-inflammatory impact 
of techniques like TAP block has not yet been 
assessed. Furthermore, when used for RA, LAs 
may also be absorbed into the systemic circula-
tion. The use of ultrasound-guided RA has led 
to a decrease in the volume of LAs administered, 
reducing not only the risk of systemic toxicity 
but perhaps also blunting expected benefits of 
LAs systemic concentrations. Finally, clinical 
observations also question the value of clinical 
markers currently used to quantify RA effect on 
the perioperative inflammation as major discrep-
Key messages
 — Local anesthetics (LAs) are the major 
component of RA technique. LAs-related 
anti-inflammatory mechanisms involve both 
the interruption of nociceptive transmission 
(reduction of neurogenic inflammation) and 
intrinsic anti-inflammatory properties un-
related to sodium channels blockade (direct 
action on immune cells). By contrast with 
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